Zura Bio Limited Stock Cash And Equivalents
| ZURA Stock | 2.73 0.20 6.83% |
Zura Bio Limited fundamentals help investors to digest information that contributes to Zura Bio's financial success or failures. It also enables traders to predict the movement of Zura Stock. The fundamental analysis module provides a way to measure Zura Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zura Bio stock.
Zura |
Zura Bio Limited Company Cash And Equivalents Analysis
Zura Bio's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Zura Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Zura Bio is extremely important. It helps to project a fair market value of Zura Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Zura Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zura Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zura Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Zura Bio Limited has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Zura Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zura Bio's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zura Bio could also be used in its relative valuation, which is a method of valuing Zura Bio by comparing valuation metrics of similar companies.Zura Bio is currently under evaluation in cash and equivalents category among its peers.
Zura Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zura Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zura Bio's managers, analysts, and investors.Environmental | Governance | Social |
Zura Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.21 | ||||
| Current Valuation | 178.59 M | ||||
| Shares Outstanding | 63.77 M | ||||
| Shares Owned By Insiders | 31.87 % | ||||
| Shares Owned By Institutions | 53.29 % | ||||
| Number Of Shares Shorted | 1.75 M | ||||
| Price To Book | 1.16 X | ||||
| EBITDA | (60.56 M) | ||||
| Net Income | (60.56 M) | ||||
| Total Debt | 21.29 M | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (15.05 M) | ||||
| Short Ratio | 5.43 X | ||||
| Earnings Per Share | 0.57 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.14 | ||||
| Market Capitalization | 295.78 M | ||||
| Total Asset | 100.84 M | ||||
| Retained Earnings | (103.49 M) | ||||
| Working Capital | 80.54 M | ||||
| Net Asset | 100.84 M |
About Zura Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zura Bio Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zura Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zura Bio Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out Zura Bio Piotroski F Score and Zura Bio Altman Z Score analysis. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.